BlackRock’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.75M Buy
+147,686
New +$2.93M ﹤0.01% 4104

Other funds holding BLSM

BlackRock's BLSM Position: Q3 2026 in Review

BlackRock opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 147,686 shares worth $2.75M. The stake represents ﹤0.01% of the portfolio and ranks #4104 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • BlackRock held 147,686 shares of BlossomHill Therapeutics worth $2.75M as of Q3 2026.
  • BlossomHill Therapeutics was a new BlackRock position in Q3 2026.
  • BlossomHill Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #4104 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.